Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Shares Outstanding (Diluted Average) (2023 - 2025)

Metagenomi (MGX) has disclosed Shares Outstanding (Diluted Average) for 3 consecutive years, with $37.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 12.79% to $37.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.3 million, a 12.79% increase, with the full-year FY2025 number at $37.3 million, up 12.79% from a year prior.
  • Shares Outstanding (Diluted Average) was $37.3 million for Q4 2025 at Metagenomi, roughly flat from $37.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $37.3 million in Q4 2025 to a low of $3.4 million in Q1 2023.
  • A 3-year average of $23.5 million and a median of $31.0 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): skyrocketed 979.91% in 2024, then grew 1.12% in 2025.
  • Metagenomi's Shares Outstanding (Diluted Average) stood at $3.4 million in 2023, then soared by 870.1% to $33.0 million in 2024, then grew by 12.79% to $37.3 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Shares Outstanding (Diluted Average) are $37.3 million (Q4 2025), $37.2 million (Q3 2025), and $37.2 million (Q2 2025).